Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
 
Treatment of blood diseases and DDS
Akio Urabe
Author information
Keywords: erythropoietin, granulocyte colony-stimulating factor, imatinib mesilate, all-trans retinoic acid, rituximab
JOURNAL FREE ACCESS

2004 Volume 19 Issue 2 Pages 90-94

Details
Download PDF (942K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract
Clinical application of hematopoietic growth factors such as erythropoietin and granulocyte colony-stimulating factor is useful in the treatment of various diseases. Moreover, molecular targeting therapy is effective in certain hematological diseases. Differentiation therapy of acute promyelocytic leukemia by all-trans retinoic acid, treatment of chronic myeIogenous leukemia by imatinib mesilate, and treatment of B cell malignant lymphoma by anti-CD20 antibody are the most popular treatments in this field.
Content from these authors
© Japan Society of Drug Delivery System
Previous article Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top